In our patient cohort with early and loco-regionally advanced TNBC, higher TROP-2 expression was associated with apocrine histology, higher AR expression, presence of DCIS, LVI and nodal involvement. The gene discussed is AR; the disease is ductal breast carcinoma in situ.